Longitudinal assessment of swallowing function in laryngeal cancer patients undergoing radiotherapy or chemoradiotherapy: a fiber-optic endoscopic evaluation of swallowing (FEES)-based study
摘要
This study evaluated swallowing outcomes in laryngeal cancer patients following radiotherapy (RT) or chemoradiotherapy (CRT).
MethodsSwallowing function was evaluated in 60 laryngeal cancer patients treated with RT/CRT using fiber-optic endoscopic evaluation of swallowing (FEES) and Arabic Dysphagia Handicap Index (A-DHI) at pretreatment (baseline) and at 2- and 6-month post-treatment.
ResultsResidue was observed in 80% of patients at baseline, increasing to 93.3% at both 2-month and 6-month posttreatment evaluations. At 6 months, there was a significant association between TNM staging and severity of residue (P-value: 0.003) and between TNM and DHI score (P-value: 0.001).
ConclusionDysphagia is a common complication of laryngeal cancer, often presented as residue, particularly with semisolid textures. Mild to moderate residue carries low aspiration risk. Residue severity and A-DHI scores worsened shortly after treatment but partially improved by the 6-month follow-up. A significant association was found between advanced TNM staging and greater residue severity at 6 months.